Announcements
- Opthea to Receive US$35M Commitment and Additional US$50M Funding
- Opthea Receives A$8.8 million R&D Tax Incentive
- Opthea to Present at the FLORetina 2023 Congress
- Opthea to Present at the Jefferies 2023 London Healthcare Conference
- Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
- Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
More ▼
Key statistics
As of last trade Opthea Ltd (UKJ2:DUS) traded at 1.65, 8.55% above its 52-week low of 1.52, set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.72 |
---|---|
High | 1.72 |
Low | 1.65 |
Bid | 1.71 |
Offer | 2.02 |
Previous close | 1.65 |
Average volume | 0.00 |
---|---|
Shares outstanding | 153.89m |
Free float | 81.39m |
P/E (TTM) | -- |
Market cap | 310.84m USD |
EPS (TTM) | -2.48 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 18:30 BST.
More ▼